Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death-Reference-Cited by-同舟云学术

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death

Published:2015-05 Issue:5 Volume:5 Page:e310-e310
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Warsame R,Kumar S K,Gertz M A,Lacy M Q,Buadi F K,Hayman S R,Leung N,Dingli D,Lust J A,Ketterling R P,Lin Y,Russell S,Hwa L,Kapoor P,Go R S,Zeldenrust S R,Kyle R A,Rajkumar S V,Dispenzieri A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201534.pdf

Reference17 articles.

1. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546–1558.

2. Hayman SR, Bailey RJ, Jalal SM, Ahmann GJ, Dispenzieri A, Gertz MA et al. Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis. Blood 2001; 98: 2266–2268.

3. Perfetti V, Coluccia AM, Intini D, Malgeri U, Vignarelli MC, Casarini S et al. Translocation T(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis. Am J Pathol 2001; 158: 1599–1603.

4. Harrison CJ, Mazzullo H, Ross FM, Cheung KL, Gerrard G, Harewood L et al. Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. Br J Haematol 2002; 117: 427–435.

5. Bryce AH, Ketterling RP, Gertz MA, Lacy M, Knudson RA, Zeldenrust S et al. Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis. Haematologica 2009; 94: 380–386.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Use of Biomarkers in Cardiac Amyloidosis;Heart Failure Clinics;2024-07

2. AL amyloidosis: an overview on diagnosis, staging system, and treatment;Frontiers in Hematology;2024-05-08

3. Light-chain Amyloidosis with Concomitant Symptomatic Myeloma (CRAB-SLiM Features): Clinical Characteristics, Cytogenetic Abnormalities, and Outcomes;2024-01-25

4. Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies;Blood Cancer Journal;2023-11-15

5. Clinical Characteristics and Outcomes of Cyclin D1–Positive AL Amyloidosis;American Journal of Clinical Pathology;2023-03-20